+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Skin Patches Market Research Report by Type, by Technology, by Application, by State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5519526
  • Report
  • January 2022
  • Region: United States
  • 119 Pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2022

FEATURED COMPANIES

  • 3M Company
  • Luye Pharma Group?
  • Mylan NV (Viatris)
  • Novartis AG?
  • Teikoku Pharma USA Inc.
The United States Transdermal Skin Patches Market size was estimated at USD 1,202.28 million in 2020, is expected to reach USD 1,359.53 million in 2021, and is projected to grow at a CAGR of 14.94% to reach USD 3,187.52 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Transdermal Skin Patches to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Matrix, Multi-layer Drug-in-Adhesive, and Single-layer Drug-in-Adhesive.
  • Based on Technology, the market was studied across Chemical Enhancers, Electric current, Mechanical arrays, and Thermal Ablation.
  • Based on Application, the market was studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction and Cessation Aid.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Skin Patches Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Transdermal Skin Patches Market, including 3M Company, Henan Lingrui Pharmaceutical Ltd, Luye Pharma Group​, Mylan NV (Viatris), Novartis AG​, Purdue Pharma Manufacturing LP, Samyang Biopharmaceuticals Corp., Teikoku Pharma USA Inc., and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Transdermal Skin Patches Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Transdermal Skin Patches Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Transdermal Skin Patches Market?
4. What is the competitive strategic window for opportunities in the United States Transdermal Skin Patches Market?
5. What are the technology trends and regulatory frameworks in the United States Transdermal Skin Patches Market?
6. What is the market share of the leading vendors in the United States Transdermal Skin Patches Market?
7. What modes and strategic moves are considered suitable for entering the United States Transdermal Skin Patches Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Luye Pharma Group?
  • Mylan NV (Viatris)
  • Novartis AG?
  • Teikoku Pharma USA Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Transdermal Skin Patches Market, by Type
6.1. Introduction
6.2. Matrix
6.3. Multi-layer Drug-in-Adhesive
6.4. Single-layer Drug-in-Adhesive

7. Transdermal Skin Patches Market, by Technology
7.1. Introduction
7.2. Chemical Enhancers
7.3. Electric current
7.4. Mechanical arrays
7.5. Thermal Ablation

8. Transdermal Skin Patches Market, by Application
8.1. Introduction
8.2. Hormonal Therapy
8.3. Overactive Bladder
8.4. Pain Relief
8.5. Smoking Reduction and Cessation Aid

9. California Transdermal Skin Patches Market

10. Florida Transdermal Skin Patches Market

11. Illinois Transdermal Skin Patches Market

12. New York Transdermal Skin Patches Market

13. Ohio Transdermal Skin Patches Market

14. Pennsylvania Transdermal Skin Patches Market

15. Texas Transdermal Skin Patches Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. 3M Company
17.2. Henan Lingrui Pharmaceutical Ltd
17.3. Luye Pharma Group​
17.4. Mylan NV (Viatris)
17.5. Novartis AG​
17.6. Purdue Pharma Manufacturing LP
17.7. Samyang Biopharmaceuticals Corp.
17.8. Teikoku Pharma USA Inc.
17.9. Teva Pharmaceutical Industries Ltd.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing


List of Figures
Figure 1. United States Transdermal Skin Patches Market: Research Process
Figure 2. United States Transdermal Skin Patches Market: Market Dynamics
Figure 3. United States Transdermal Skin Patches Market Size, by Type, 2020 Vs 2027 (%)
Figure 4. United States Transdermal Skin Patches Market Size, by Type, 2020 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For United States Transdermal Skin Patches Market Size, by Type, 2027
Figure 6. United States Transdermal Skin Patches Market Size, by Matrix, 2018-2027 (USD Million)
Figure 7. United States Transdermal Skin Patches Market Size, by Matrix, by State, 2020 Vs 2027 (USD Million)
Figure 8. United States Transdermal Skin Patches Market Size, by Multi-Layer Drug-In-Adhesive, 2018-2027 (USD Million)
Figure 9. United States Transdermal Skin Patches Market Size, by Multi-Layer Drug-In-Adhesive, by State, 2020 Vs 2027 (USD Million)
Figure 10. United States Transdermal Skin Patches Market Size, by Single-Layer Drug-In-Adhesive, 2018-2027 (USD Million)
Figure 11. United States Transdermal Skin Patches Market Size, by Single-Layer Drug-In-Adhesive, by State, 2020 Vs 2027 (USD Million)
Figure 12. United States Transdermal Skin Patches Market Size, by Technology, 2020 Vs 2027 (%)
Figure 13. United States Transdermal Skin Patches Market Size, by Technology, 2020 Vs 2027 (USD Million)
Figure 14. Competitive Strategic Window For United States Transdermal Skin Patches Market Size, by Technology, 2027
Figure 15. United States Transdermal Skin Patches Market Size, by Chemical Enhancers, 2018-2027 (USD Million)
Figure 16. United States Transdermal Skin Patches Market Size, by Chemical Enhancers, by State, 2020 Vs 2027 (USD Million)
Figure 17. United States Transdermal Skin Patches Market Size, by Electric Current, 2018-2027 (USD Million)
Figure 18. United States Transdermal Skin Patches Market Size, by Electric Current, by State, 2020 Vs 2027 (USD Million)
Figure 19. United States Transdermal Skin Patches Market Size, by Mechanical Arrays, 2018-2027 (USD Million)
Figure 20. United States Transdermal Skin Patches Market Size, by Mechanical Arrays, by State, 2020 Vs 2027 (USD Million)
Figure 21. United States Transdermal Skin Patches Market Size, by Thermal Ablation, 2018-2027 (USD Million)
Figure 22. United States Transdermal Skin Patches Market Size, by Thermal Ablation, by State, 2020 Vs 2027 (USD Million)
Figure 23. United States Transdermal Skin Patches Market Size, by Application, 2020 Vs 2027 (%)
Figure 24. United States Transdermal Skin Patches Market Size, by Application, 2020 Vs 2027 (USD Million)
Figure 25. Competitive Strategic Window For United States Transdermal Skin Patches Market Size, by Application, 2027
Figure 26. United States Transdermal Skin Patches Market Size, by Hormonal Therapy, 2018-2027 (USD Million)
Figure 27. United States Transdermal Skin Patches Market Size, by Hormonal Therapy, by State, 2020 Vs 2027 (USD Million)
Figure 28. United States Transdermal Skin Patches Market Size, by Overactive Bladder, 2018-2027 (USD Million)
Figure 29. United States Transdermal Skin Patches Market Size, by Overactive Bladder, by State, 2020 Vs 2027 (USD Million)
Figure 30. United States Transdermal Skin Patches Market Size, by Pain Relief, 2018-2027 (USD Million)
Figure 31. United States Transdermal Skin Patches Market Size, by Pain Relief, by State, 2020 Vs 2027 (USD Million)
Figure 32. United States Transdermal Skin Patches Market Size, by Smoking Reduction And Cessation Aid, 2018-2027 (USD Million)
Figure 33. United States Transdermal Skin Patches Market Size, by Smoking Reduction And Cessation Aid, by State, 2020 Vs 2027 (USD Million)
Figure 34. United States Transdermal Skin Patches Market: Fpnv Positioning Matrix
Figure 35. United States Transdermal Skin Patches Market: Share, by Key Player, 2020
Figure 36. Competitive Scenario Analysis In United States Transdermal Skin Patches Market, by Type


List of Tables
Table 1. United States Transdermal Skin Patches Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. United States Transdermal Skin Patches Market Size, by Type, 2018-2027 (USD Million)
Table 4. United States Transdermal Skin Patches Market Size, by Matrix, by State, 2018-2027 (USD Million)
Table 5. United States Transdermal Skin Patches Market Size, by Multi-Layer Drug-In-Adhesive, by State, 2018-2027 (USD Million)
Table 6. United States Transdermal Skin Patches Market Size, by Single-Layer Drug-In-Adhesive, by State, 2018-2027 (USD Million)
Table 7. United States Transdermal Skin Patches Market Size, by Technology, 2018-2027 (USD Million)
Table 8. United States Transdermal Skin Patches Market Size, by Chemical Enhancers, by State, 2018-2027 (USD Million)
Table 9. United States Transdermal Skin Patches Market Size, by Electric Current, by State, 2018-2027 (USD Million)
Table 10. United States Transdermal Skin Patches Market Size, by Mechanical Arrays, by State, 2018-2027 (USD Million)
Table 11. United States Transdermal Skin Patches Market Size, by Thermal Ablation, by State, 2018-2027 (USD Million)
Table 12. United States Transdermal Skin Patches Market Size, by Application, 2018-2027 (USD Million)
Table 13. United States Transdermal Skin Patches Market Size, by Hormonal Therapy, by State, 2018-2027 (USD Million)
Table 14. United States Transdermal Skin Patches Market Size, by Overactive Bladder, by State, 2018-2027 (USD Million)
Table 15. United States Transdermal Skin Patches Market Size, by Pain Relief, by State, 2018-2027 (USD Million)
Table 16. United States Transdermal Skin Patches Market Size, by Smoking Reduction And Cessation Aid, by State, 2018-2027 (USD Million)
Table 17. United States Transdermal Skin Patches Market: Scores
Table 18. United States Transdermal Skin Patches Market: Business Strategy
Table 19. United States Transdermal Skin Patches Market: Product Satisfaction
Table 20. United States Transdermal Skin Patches Market: Ranking
Table 21. United States Transdermal Skin Patches Market: Share, by Key Player, 2020
Table 22. United States Transdermal Skin Patches Market: Merger & Acquisition
Table 23. United States Transdermal Skin Patches Market: Agreement, Collaboration, & Partnership
Table 24. United States Transdermal Skin Patches Market: New Product Launch & Enhancement
Table 25. United States Transdermal Skin Patches Market: Investment & Funding
Table 26. United States Transdermal Skin Patches Market: Award, Recognition, & Expansion
Table 27. United States Transdermal Skin Patches Market: License & Pricing
Note: Product cover images may vary from those shown
  • 3M Company
  • Henan Lingrui Pharmaceutical Ltd
  • Luye Pharma Group​
  • Mylan NV (Viatris)
  • Novartis AG​
  • Purdue Pharma Manufacturing LP
  • Samyang Biopharmaceuticals Corp.
  • Teikoku Pharma USA Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...